Global Multiple Sclerosis Drugs Market Research Report 2017

October 2017 | 107 pages | ID: G7C5AC06987PEN
QYResearch

Abstracts

In this report, the global Multiple Sclerosis Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Multiple Sclerosis Drugs in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Multiple Sclerosis Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Biogen
• Teva Pharmaceutical
• Merck KGaA
• Novartis
• Bayer
• Sanofi
• Acorda Therapeutics
• Questcor Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Oral
• Injectable
• Intravenous

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Multiple Sclerosis Drugs for each application, including

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Multiple Sclerosis Drugs Market Research Report 2017

1 MULTIPLE SCLEROSIS DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Multiple Sclerosis Drugs
1.2 Multiple Sclerosis Drugs Segment by Type (Product Category)
  1.2.1 Global Multiple Sclerosis Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Multiple Sclerosis Drugs Production Market Share by Type (Product Category) in 2016
  1.2.3 Oral
  1.2.4 Injectable
  1.2.5 Intravenous
1.3 Global Multiple Sclerosis Drugs Segment by Application
  1.3.1 Multiple Sclerosis Drugs Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 Global Multiple Sclerosis Drugs Market by Region (2012-2022)
  1.4.1 Global Multiple Sclerosis Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Multiple Sclerosis Drugs (2012-2022)
  1.5.1 Global Multiple Sclerosis Drugs Revenue Status and Outlook (2012-2022)
  1.5.2 Global Multiple Sclerosis Drugs Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL MULTIPLE SCLEROSIS DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Multiple Sclerosis Drugs Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Multiple Sclerosis Drugs Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Multiple Sclerosis Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Multiple Sclerosis Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Multiple Sclerosis Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Multiple Sclerosis Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Multiple Sclerosis Drugs Market Competitive Situation and Trends
  2.5.1 Multiple Sclerosis Drugs Market Concentration Rate
  2.5.2 Multiple Sclerosis Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL MULTIPLE SCLEROSIS DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Multiple Sclerosis Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Multiple Sclerosis Drugs Production and Market Share by Region (2012-2017)
3.3 Global Multiple Sclerosis Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL MULTIPLE SCLEROSIS DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Multiple Sclerosis Drugs Consumption by Region (2012-2017)
4.2 North America Multiple Sclerosis Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Multiple Sclerosis Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Multiple Sclerosis Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Multiple Sclerosis Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Multiple Sclerosis Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Multiple Sclerosis Drugs Production, Consumption, Export, Import (2012-2017)

5 GLOBAL MULTIPLE SCLEROSIS DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Multiple Sclerosis Drugs Production and Market Share by Type (2012-2017)
5.2 Global Multiple Sclerosis Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Multiple Sclerosis Drugs Price by Type (2012-2017)
5.4 Global Multiple Sclerosis Drugs Production Growth by Type (2012-2017)

6 GLOBAL MULTIPLE SCLEROSIS DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Multiple Sclerosis Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Multiple Sclerosis Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL MULTIPLE SCLEROSIS DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Biogen
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Multiple Sclerosis Drugs Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Biogen Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Teva Pharmaceutical
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Multiple Sclerosis Drugs Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Teva Pharmaceutical Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 Merck KGaA
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Multiple Sclerosis Drugs Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Merck KGaA Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Novartis
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Multiple Sclerosis Drugs Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Novartis Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Bayer
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Multiple Sclerosis Drugs Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Bayer Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Sanofi
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Multiple Sclerosis Drugs Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Sanofi Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Acorda Therapeutics
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Multiple Sclerosis Drugs Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Acorda Therapeutics Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Questcor Pharmaceuticals
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Multiple Sclerosis Drugs Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Questcor Pharmaceuticals Multiple Sclerosis Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview

8 MULTIPLE SCLEROSIS DRUGS MANUFACTURING COST ANALYSIS

8.1 Multiple Sclerosis Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Multiple Sclerosis Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Multiple Sclerosis Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Multiple Sclerosis Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL MULTIPLE SCLEROSIS DRUGS MARKET FORECAST (2017-2022)

12.1 Global Multiple Sclerosis Drugs Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Multiple Sclerosis Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Multiple Sclerosis Drugs Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Multiple Sclerosis Drugs Price and Trend Forecast (2017-2022)
12.2 Global Multiple Sclerosis Drugs Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Multiple Sclerosis Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Multiple Sclerosis Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Multiple Sclerosis Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Multiple Sclerosis Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Multiple Sclerosis Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Multiple Sclerosis Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Multiple Sclerosis Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Multiple Sclerosis Drugs Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Multiple Sclerosis Drugs
Figure Global Multiple Sclerosis Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Multiple Sclerosis Drugs Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Oral
Table Major Manufacturers of Oral
Figure Product Picture of Injectable
Table Major Manufacturers of Injectable
Figure Product Picture of Intravenous
Table Major Manufacturers of Intravenous
Figure Global Multiple Sclerosis Drugs Consumption (K Units) by Applications (2012-2022)
Figure Global Multiple Sclerosis Drugs Consumption Market Share by Applications in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure Global Multiple Sclerosis Drugs Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Multiple Sclerosis Drugs Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Multiple Sclerosis Drugs Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Multiple Sclerosis Drugs Major Players Product Capacity (K Units) (2012-2017)
Table Global Multiple Sclerosis Drugs Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Multiple Sclerosis Drugs Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Multiple Sclerosis Drugs Capacity (K Units) of Key Manufacturers in 2016
Figure Global Multiple Sclerosis Drugs Capacity (K Units) of Key Manufacturers in 2017
Figure Global Multiple Sclerosis Drugs Major Players Product Production (K Units) (2012-2017)
Table Global Multiple Sclerosis Drugs Production (K Units) of Key Manufacturers (2012-2017)
Table Global Multiple Sclerosis Drugs Production Share by Manufacturers (2012-2017)
Figure 2016 Multiple Sclerosis Drugs Production Share by Manufacturers
Figure 2017 Multiple Sclerosis Drugs Production Share by Manufacturers
Figure Global Multiple Sclerosis Drugs Major Players Product Revenue (Million USD) (2012-2017)
Table Global Multiple Sclerosis Drugs Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Multiple Sclerosis Drugs Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Multiple Sclerosis Drugs Revenue Share by Manufacturers
Table 2017 Global Multiple Sclerosis Drugs Revenue Share by Manufacturers
Table Global Market Multiple Sclerosis Drugs Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Multiple Sclerosis Drugs Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Multiple Sclerosis Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Multiple Sclerosis Drugs Product Category
Figure Multiple Sclerosis Drugs Market Share of Top 3 Manufacturers
Figure Multiple Sclerosis Drugs Market Share of Top 5 Manufacturers
Table Global Multiple Sclerosis Drugs Capacity (K Units) by Region (2012-2017)
Figure Global Multiple Sclerosis Drugs Capacity Market Share by Region (2012-2017)
Figure Global Multiple Sclerosis Drugs Capacity Market Share by Region (2012-2017)
Figure 2016 Global Multiple Sclerosis Drugs Capacity Market Share by Region
Table Global Multiple Sclerosis Drugs Production by Region (2012-2017)
Figure Global Multiple Sclerosis Drugs Production (K Units) by Region (2012-2017)
Figure Global Multiple Sclerosis Drugs Production Market Share by Region (2012-2017)
Figure 2016 Global Multiple Sclerosis Drugs Production Market Share by Region
Table Global Multiple Sclerosis Drugs Revenue (Million USD) by Region (2012-2017)
Table Global Multiple Sclerosis Drugs Revenue Market Share by Region (2012-2017)
Figure Global Multiple Sclerosis Drugs Revenue Market Share by Region (2012-2017)
Table 2016 Global Multiple Sclerosis Drugs Revenue Market Share by Region
Figure Global Multiple Sclerosis Drugs Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Multiple Sclerosis Drugs Consumption (K Units) Market by Region (2012-2017)
Table Global Multiple Sclerosis Drugs Consumption Market Share by Region (2012-2017)
Figure Global Multiple Sclerosis Drugs Consumption Market Share by Region (2012-2017)
Figure 2016 Global Multiple Sclerosis Drugs Consumption (K Units) Market Share by Region
Table North America Multiple Sclerosis Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Multiple Sclerosis Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Multiple Sclerosis Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Multiple Sclerosis Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Multiple Sclerosis Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Multiple Sclerosis Drugs Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Multiple Sclerosis Drugs Production (K Units) by Type (2012-2017)
Table Global Multiple Sclerosis Drugs Production Share by Type (2012-2017)
Figure Production Market Share of Multiple Sclerosis Drugs by Type (2012-2017)
Figure 2016 Production Market Share of Multiple Sclerosis Drugs by Type
Table Global Multiple Sclerosis Drugs Revenue (Million USD) by Type (2012-2017)
Table Global Multiple Sclerosis Drugs Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Multiple Sclerosis Drugs by Type (2012-2017)
Figure 2016 Revenue Market Share of Multiple Sclerosis Drugs by Type
Table Global Multiple Sclerosis Drugs Price (USD/Unit) by Type (2012-2017)
Figure Global Multiple Sclerosis Drugs Production Growth by Type (2012-2017)
Table Global Multiple Sclerosis Drugs Consumption (K Units) by Application (2012-2017)
Table Global Multiple Sclerosis Drugs Consumption Market Share by Application (2012-2017)
Figure Global Multiple Sclerosis Drugs Consumption Market Share by Applications (2012-2017)
Figure Global Multiple Sclerosis Drugs Consumption Market Share by Application in 2016
Table Global Multiple Sclerosis Drugs Consumption Growth Rate by Application (2012-2017)
Figure Global Multiple Sclerosis Drugs Consumption Growth Rate by Application (2012-2017)
Table Biogen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biogen Multiple Sclerosis Drugs Production Growth Rate (2012-2017)
Figure Biogen Multiple Sclerosis Drugs Production Market Share (2012-2017)
Figure Biogen Multiple Sclerosis Drugs Revenue Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Multiple Sclerosis Drugs Production Growth Rate (2012-2017)
Figure Teva Pharmaceutical Multiple Sclerosis Drugs Production Market Share (2012-2017)
Figure Teva Pharmaceutical Multiple Sclerosis Drugs Revenue Market Share (2012-2017)
Table Merck KGaA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck KGaA Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck KGaA Multiple Sclerosis Drugs Production Growth Rate (2012-2017)
Figure Merck KGaA Multiple Sclerosis Drugs Production Market Share (2012-2017)
Figure Merck KGaA Multiple Sclerosis Drugs Revenue Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Multiple Sclerosis Drugs Production Growth Rate (2012-2017)
Figure Novartis Multiple Sclerosis Drugs Production Market Share (2012-2017)
Figure Novartis Multiple Sclerosis Drugs Revenue Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer Multiple Sclerosis Drugs Production Growth Rate (2012-2017)
Figure Bayer Multiple Sclerosis Drugs Production Market Share (2012-2017)
Figure Bayer Multiple Sclerosis Drugs Revenue Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Multiple Sclerosis Drugs Production Growth Rate (2012-2017)
Figure Sanofi Multiple Sclerosis Drugs Production Market Share (2012-2017)
Figure Sanofi Multiple Sclerosis Drugs Revenue Market Share (2012-2017)
Table Acorda Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acorda Therapeutics Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Acorda Therapeutics Multiple Sclerosis Drugs Production Growth Rate (2012-2017)
Figure Acorda Therapeutics Multiple Sclerosis Drugs Production Market Share (2012-2017)
Figure Acorda Therapeutics Multiple Sclerosis Drugs Revenue Market Share (2012-2017)
Table Questcor Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Questcor Pharmaceuticals Multiple Sclerosis Drugs Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Questcor Pharmaceuticals Multiple Sclerosis Drugs Production Growth Rate (2012-2017)
Figure Questcor Pharmaceuticals Multiple Sclerosis Drugs Production Market Share (2012-2017)
Figure Questcor Pharmaceuticals Multiple Sclerosis Drugs Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Multiple Sclerosis Drugs
Figure Manufacturing Process Analysis of Multiple Sclerosis Drugs
Figure Multiple Sclerosis Drugs Industrial Chain Analysis
Table Raw Materials Sources of Multiple Sclerosis Drugs Major Manufacturers in 2016
Table Major Buyers of Multiple Sclerosis Drugs
Table Distributors/Traders List
Figure Global Multiple Sclerosis Drugs Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Multiple Sclerosis Drugs Price (Million USD) and Trend Forecast (2017-2022)
Table Global Multiple Sclerosis Drugs Production (K Units) Forecast by Region (2017-2022)
Figure Global Multiple Sclerosis Drugs Production Market Share Forecast by Region (2017-2022)
Table Global Multiple Sclerosis Drugs Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Multiple Sclerosis Drugs Consumption Market Share Forecast by Region (2017-2022)
Figure North America Multiple Sclerosis Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Multiple Sclerosis Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Multiple Sclerosis Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Multiple Sclerosis Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Multiple Sclerosis Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Multiple Sclerosis Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Multiple Sclerosis Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Multiple Sclerosis Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Multiple Sclerosis Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Multiple Sclerosis Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Multiple Sclerosis Drugs Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Multiple Sclerosis Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Multiple Sclerosis Drugs Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Multiple Sclerosis Drugs Production (K Units) Forecast by Type (2017-2022)
Figure Global Multiple Sclerosis Drugs Production (K Units) Forecast by Type (2017-2022)
Table Global Multiple Sclerosis Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Multiple Sclerosis Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Multiple Sclerosis Drugs Price Forecast by Type (2017-2022)
Table Global Multiple Sclerosis Drugs Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Multiple Sclerosis Drugs Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source